These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7628033)

  • 1. The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation.
    Gilron I
    Can J Anaesth; 1995 Jun; 42(6):516-22. PubMed ID: 7628033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.
    van den Berg JP; Vereecke HE; Proost JH; Eleveld DJ; Wietasch JK; Absalom AR; Struys MM
    Br J Anaesth; 2017 Jan; 118(1):44-57. PubMed ID: 28039241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An introduction to predictive modelling of drug concentration in anaesthesia monitors.
    DeCou J; Johnson K
    Anaesthesia; 2017 Jan; 72 Suppl 1():58-69. PubMed ID: 28044328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Off label" use of some medicinal products. Part I].
    Sirakov M
    Akush Ginekol (Sofiia); 2012; 51(2):29-32. PubMed ID: 23234011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to manage drug interactions.
    Glass PS; Howell S; Gan TJ; Ginsberg B
    Eur J Anaesthesiol Suppl; 1997 May; 15():33-9. PubMed ID: 9202936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug interactions in anesthesiology].
    Kübler A
    Pol Merkur Lekarski; 2000 Sep; 9(51):598-9. PubMed ID: 11126982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug regulation and policy formulation.
    Nightingale SL
    Milbank Mem Fund Q Health Soc; 1981; 59(3):412-44. PubMed ID: 7024847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-operative drug prescribing pattern and manufacturers' guidelines. An audit.
    Kluger MT; Gale S; Plummer JL; Owen H
    Anaesthesia; 1991 Jun; 46(6):456-9. PubMed ID: 2048662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug development in oncology: a regulatory perspective.
    Augustus S
    Am J Ther; 2011 Jul; 18(4):323-31. PubMed ID: 20335790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should the pharmaceutical industry play an active part in pharmacosurveillance? (author's transl)].
    d'Azemar P; Alexandre C; Thomas J
    Anesth Analg (Paris); 1980; 37(9-10):537-42. PubMed ID: 7469070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Regulation and Pricing--Can Regulators Influence Affordability?
    Eichler HG; Hurts H; Broich K; Rasi G
    N Engl J Med; 2016 May; 374(19):1807-9. PubMed ID: 27168431
    [No Abstract]   [Full Text] [Related]  

  • 16. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin.
    Abraham J
    Soc Sci Med; 2010 Mar; 70(5):648-51. PubMed ID: 20056525
    [No Abstract]   [Full Text] [Related]  

  • 19. Harmonization, regulation, and trade: interactions in the pharmaceutical field.
    Timmermans K
    Int J Health Serv; 2004; 34(4):651-61. PubMed ID: 15560428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical counterfeiting.
    Deisingh AK
    Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.